Ovidika® (Suppositories) Instructions for Use
Marketing Authorization Holder
Pharmaprim, LLC (Republic of Moldova)
ATC Code
G01AX11 (Povidone-iodine)
Active Substance
Povidone-iodine (BAN)
Dosage Form
| Ovidika® | Vaginal suppositories 200 mg: 14 pcs. |
Dosage Form, Packaging, and Composition
Vaginal suppositories of a torpedo-like shape, brown in color, with a specific odor of iodine; a longitudinal section may show the presence of an air core or a funnel-shaped depression.
| 1 supp. | |
| Povidone-iodine | 200 mg |
Excipients: macrogol 1000 – 1800 mg.
7 pcs. – contour cell packs (2) – cardboard packs.
Clinical-Pharmacological Group
Topical antiseptic for use in gynecology
Pharmacotherapeutic Group
Antimicrobial agents and antiseptics used in gynecology; antimicrobial agents and antiseptics, except combinations with corticosteroids; other antimicrobial agents and antiseptics
Pharmacological Action
It has antiseptic, disinfectant, antifungal, and antiprotozoal action. It blocks the amino groups of cellular proteins. It has a broad spectrum of antimicrobial action. Active against bacteria (including E. coli, Staphylococcus aureus), fungi, viruses, protozoa.
When released from the complex with polyvinylpyrrolidone upon contact with the skin and mucous membranes, iodine forms iodamines with bacterial cell proteins, coagulates them, and causes the death of microorganisms.
It has a rapid bactericidal effect on gram-positive and gram-negative bacteria (except for Mycobacterium tuberculosis).
Pharmacokinetics
With topical application, almost no absorption of iodine from the mucous membrane occurs.
Indications
Acute or chronic vaginitis (mixed, nonspecific infection); bacterial vaginosis (caused by Gardnerella vaginalis); candidiasis; Trichomonas vaginalis infection; vaginal infections after therapy with antibiotics or steroid drugs; prophylaxis before surgical or diagnostic interventions in the vagina.
ICD codes
| ICD-10 code | Indication |
| A59 | Trichomoniasis |
| B37.3 | Candidiasis of vulva and vagina |
| N76 | Other inflammatory diseases of vagina and vulva |
| N77.1 | Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere |
| N89.8 | Other noninflammatory disorders of vagina |
| Z29.8 | Other specified prophylactic measures |
| ICD-11 code | Indication |
| 1A92 | Trichomoniasis |
| 1F23.10 | Candidiasis of vulva and vagina |
| 1F65 | Enterobiasis |
| 1H0Z | Unspecified infection |
| GA00 | Vulvitis |
| GA02.Z | Unspecified vaginitis |
| GA0Z | Inflammatory diseases of female genital tract, unspecified |
| GC42.1 | Painful intercourse |
| MF3A | Vaginal discharge |
| QC05.Z | Prophylactic measures, unspecified |
| 1A94.0 | Genital or urogenital tract infection caused by Herpes simplex virus |
| GA41 | Ulcerative or erosive diseases of vulva |
| GA1Z | Unspecified noninflammatory disorders of female genital tract |
| XA1LK7 | Vagina |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer one suppository intravaginally, once or twice daily.
Determine the duration of treatment individually based on clinical indication and response.
Continue treatment during menstruation without interruption.
For preoperative or diagnostic prophylaxis, follow the specific regimen prescribed by the physician.
Wash hands thoroughly before and after handling the suppository.
Insert the suppository deeply into the vagina while lying on your back with knees bent.
Use a sanitary pad to protect clothing from potential staining, as the suppository melts at body temperature.
Adverse Reactions
Local reactions rarely – itching, hyperemia, hypersensitivity reactions.
In rare cases, the development of a hypersensitivity reaction is possible, for example, contact dermatitis with the formation of psoriasiform red small bullous elements. If such phenomena occur, the use of the drug should be discontinued.
Long-term use of povidone-iodine can lead to the absorption of significant amounts of iodine. In some cases, the development of iodine-induced hyperthyroidism has been described, mainly in patients with pre-existing thyroid disease.
Contraindications
Hypersensitivity to iodine; thyroid dysfunction (nodular colloid goiter, endemic goiter and Hashimoto’s thyroiditis, hyperthyroidism); acute thyroid diseases; thyroid adenoma; Duhring’s dermatitis herpetiformis; before and during the use of radioactive iodine for the treatment of thyroid carcinoma or scintigraphy; pregnancy, breastfeeding period; girls who have not reached adolescence.
Use in Pregnancy and Lactation
Contraindicated for use during pregnancy and breastfeeding.
Use in Renal Impairment
Caution should be exercised with regular use of the drug in patients with previously diagnosed renal failure.
Pediatric Use
The use of povidone-iodine is allowed from the neonatal period, but considering the dosage form – vaginal suppositories – it is not recommended for use in girls under 8 years of age and caution should be exercised when administering to virgins.
Geriatric Use
Use with caution in elderly patients to avoid the risk of exacerbation of chronic diseases.
Special Precautions
Due to the oxidative properties of povidone-iodine, its traces can lead to false-positive results of some types of tests for the detection of occult blood in the stool, as well as blood or glucose in the urine.
During the use of povidone-iodine, the uptake of iodine by the thyroid gland may decrease, which may affect the results of some diagnostic tests (e.g., thyroid scintigraphy, protein-bound iodine determination, measurements using radioactive iodine), and may also interact with iodine preparations used to treat thyroid diseases. To obtain undistorted results of thyroid scintigraphy after long-term therapy with povidone-iodine, it is recommended to allow a sufficiently long period of time without this drug.
In case of thyroid dysfunction, the drug can be used only as directed by a doctor. If symptoms of hyperthyroidism occur during the course of treatment, thyroid function should be checked.
Caution should be exercised with regular use of the drug in patients with previously diagnosed renal failure.
Regular use of preparations containing Povidone-iodine should be avoided in patients receiving lithium preparations.
Drug Interactions
Incompatible with other disinfectant and antiseptic agents, especially those containing alkalis, enzymes, and mercury.
Concomitant use of povidone-iodine and hydrogen peroxide, as well as enzyme preparations containing silver and taurolidine for wound treatment, as well as antiseptic preparations, leads to a mutual decrease in effectiveness.
In the presence of blood, the bactericidal effect may decrease; however, with an increase in the concentration of the active substance, bactericidal activity may be increased.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Mildronate capsules 500mg, 90pcs
Belosalic, ointment, 30g
No-spa pills 40mg, 64pcs
Actovegin pills 200mg, 50pcs
Cortexin, 10mg, 5ml, 10pcs
Belosalic, lotion solution for external use spray 100ml
Daivobet, ointment, 30g
Kagocel pills 12mg, 30pcs
Picamilon pills 50mg, 60pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Ingavirin capsules 90mg, 10pcs
Fenotropil pills 100mg, 60pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Nootropil pills 800mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Noopept, pills 10mg, 50pcs
Arbidol, capsules 100mg, 40pcs
Phenibut-Vertex pills 250mg, 20pcs 